Home/ Stocks/ VYNE

VYNE Therapeutics Inc. Common Stock

VYNE XNAS

$0.66 -0.01 (-1.71%) ▼ 15-min delayed

Open

$0.66

High

$0.68

Low

$0.65

Volume

72.2K

Market Cap

$22.03M

About VYNE Therapeutics Inc. Common Stock

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 10 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$570.0K	$-26,483,000	$-0.62
FY 2025	$570.0K	$-26,483,000	$-0.62
Q2 2025	$69.0K	$-5,755,000	$-0.13
Q1 2025	$202.0K	$-8,611,000	$-0.20

Related Market News

No specific coverage for VYNE yet. Check out our latest market news or earnings calendar.

Get VYNE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on VYNE Therapeutics Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.